Anticancer activity of a new pharmaceutical composition of diindolylmethane by inhibiting the cell viability in vitro

Cover Page
  • Authors: Kiselev VI1, Drukh VM1, Pchelintseva OI1, Kuznetsov IN2, Muyzhnek EL3, Gorbunova EA4
  • Affiliations:
    1. Peoples' Friendship University of Russia
    2. Moscow State Medical Stomatological University (MGMSU) n.a. A.I. Evdokimov
    3. ZAO «MiraxBioPharma»
    4. Research Center for Obstetrics, Gynecology and Perinatology
  • Issue: No 2 (2014)
  • Pages: 95-101
  • Section: Articles
  • URL: http://journals.rudn.ru/medicine/article/view/2864
  • Cite item

Abstract


We have studied antitumor effects of a new pharmaceutical composition with improved bioavailability containing 3,3’-diindolylmethane (DIM) by in vitro modelling. Cytotoxicity of the test substance was determined by MTT assay. Pharmaceutical composition based on DIM inhibits the growth of tumor cell lines of endometrial cancer CRL-1622 (IC50 = 41,9 µM) and HTB-113 (IC50 = 52,2 µM). Results of the study allow to recommend the further investigation of antitumor activity in vivo .

About the authors

V I Kiselev

Peoples' Friendship University of Russia

Email: ekazueva@yandex.ru. vkis10@mail.ru

V M Drukh

Peoples' Friendship University of Russia

Email: DruhVM@ilmixgroup.ru

O I Pchelintseva

Peoples' Friendship University of Russia

Email: pchelintseva87@mail.ru

I N Kuznetsov

Moscow State Medical Stomatological University (MGMSU) n.a. A.I. Evdokimov

Email: Kuznetsovin@ilmixgroup.ru

E L Muyzhnek

ZAO «MiraxBioPharma»

Email: MuyzhnekEL@ilmixgroup.ru

E A Gorbunova

Research Center for Obstetrics, Gynecology and Perinatology

Email: fiestagor@gmail.com

References

Statistics

Views

Abstract - 197

PDF (Russian) - 60

Cited-By



Copyright (c) 2014 Киселев В.И., Друх В.М., Пчелинцева О.И., Кузнецов И.Н., Муйжнек Е.Л., Горбунова Е.А.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies